A grant will establish the new Bachmann-Strauss Dystonia and Parkinson’s Disease Centers of Excellence at UAB and two other medical centers.
Can smell tests reveal brain changes that are precursors to Parkinson's? Research podcast with David Standaert, M.D., Ph.D.
UAB Neurology study adds to evidence that massive, second-wave reaction kills nerve cells.
UAB researchers have identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson’s disease.